Accounts Payable

9 Months Ended

Sep. 30, 2017

Accounts Payable Disclosure [Abstract]

Accounts Payable

5. Accounts Payable

As of September 30, 2017, Current Liabilities included accounts payable of $0.1 million, comprised primarily of amounts owed for preclinical studies, legal fees and manufacturing development and testing services. As of December 31, 2016, Current Liabilities included accounts payable of $0.1 million.